Location: Home
  • search
  • go
  • Relate News
  • 11/23/2017Expect More US Corruption Probes Involving Firms with Links to China
  • 11/23/2017Investors Place Bet on Chinese Drugmakers
  • 11/23/2017China's FDA Reform Will Encourage Life Science Innovation
  • 11/23/2017NDRC Issues the Guidelines for Pricing Behaviors of Shortage Drug and ...
  • 11/23/2017Chinese Premier Intervenes Leukemia Drug Supply amid Growing Shortages...
  • 11/23/2017CDE Publicizes Batch 24 of Drug Applications To Be Granted Priority Re...
  • 11/23/2017CAR-T Startup Immunochina Raises CNY 50M to Further Its Cell and Gene ...
  • 11/23/2017CFDA Approves Clinical Trial of Chinese-developed 2nd Generation HPV V...
  • 11/22/2017Chinese CRO Market Expected to Rise Fast by 2022
  • 11/22/2017Eleison Pharma to Partner with Lee's Pharma for Glufosfamide in China
  • 11/22/2017Lee's Pharm, Shenogen in Partnership Again for Anticancer Combo Deal
  • 11/22/2017Guangzhou Pharma Reveals Grand Plan
  • 11/22/2017CFDA Issues Amendments of Eight Food and Drug Regulations
  • 11/22/2017Fresenius Kabi Terminates Oncology Business Division in China
  • 11/22/2017Sichuan Kelun Pharma Acquires 20% Stake of Competitor Shijiazhuang No....
  • 11/22/2017PwC: Overseas Investments by Chinese Pharma Cos Up as Domestic M&A...
  • 11/22/2017China Embraces AI for Diagnosis of Lung Cancer
  • 11/22/2017RiboBio and GE Healthcare Forges Partnership for Oligonucleotide Drug ...
  • 11/21/2017Chengdu Kanghong Pharma to Acquire Israel's IOPtima
  • 11/20/2017Acasti Pharma to License Its Hypertriglyceridemia Drug to Chinese Part...
  • 11/19/2017Listed Chinese Pharma Cos Remain Major Advertisers in H1/2017
  • 11/19/2017Domestically-listed Companies Maintains Growth in First 3Qs of 2017
  • 11/17/2017CFDA Solicits Comments on Draft Amendment to the Rules for CFDA Legisl...
  • 11/16/2017Recent Official and Executive Moves
  • 11/16/2017Shanghai Pharma Eyes Acquisitions in the U.S. and Europe Following Car...
  • 11/16/2017CIRC Releases Draft Amendment of Health Insurance Regulation
  • 11/15/2017Fujian-led Inter-provincial Drug Purchase Alliance Imminent
  • 11/15/2017Ascentage Announces U.S. FDA Acceptance of Its IND for Novel IAP Inhib...
  • 11/15/2017Update on Antitrust Legislative Development in China
  • 11/15/2017Competition Impact Review to Be Required for All New Chinese Regulatio...
  • Page:371/802 Total number of articles:24050: [First][<<] [369] [370] [371] [372] [373] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group